Boston Scientific (BSX) Revenue — Quarter Ended Jun 30, 2023
Revenue increased in the reported quarter. The growth rate was higher than both the immediately preceding quarter and the same quarter one year earlier.
Key takeaway
Quarter ended Jun 30, 2023 · FY2023 Q2
Revenue increased in the reported quarter. The growth rate was higher than both the immediately preceding quarter and the same quarter one year earlier.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$3.6B
Revenue reported for this quarter.
Quarter-over-quarter
+6.2%
Change from the immediately preceding quarter.
Year-over-year
+10.9%
Change from the comparable year-ago quarter.
Trailing four quarters
$13.4B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2022 | $3.2B | +8.1% |
| Dec 31, 2022 | $3.2B | +3.7% |
| Mar 31, 2023 | $3.4B | +12.0% |
| Jun 30, 2023 | $3.6B | +10.9% |
Revenue performance
The company reported revenue growth across all its major segments, with operational improvements contributing to the overall increase.
Quarterly comparison
Sequentially, revenue rose from the preceding quarter. Year-over-year, the revenue was significantly higher than the comparable period one year ago.
What to watch
The negative effect of foreign currency fluctuations on revenue growth, as disclosed in the filing, is a factor to watch.